Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Disorders of the Nervous System

Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells

Amber Anees, Hannah E. Salapa, Patricia A. Thibault, Catherine Hutchinson, S. Austin Hammond and Michael C. Levin
eNeuro 25 October 2021, 8 (6) ENEURO.0350-21.2021; https://doi.org/10.1523/ENEURO.0350-21.2021
Amber Anees
1Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, CMSNRC (Cameco MS Neuroscience Research Center), College of Medicine, University of Saskatchewan, Saskatoon, SK, S7K 0M7, Canada
3Department of Health Sciences, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amber Anees
Hannah E. Salapa
1Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, CMSNRC (Cameco MS Neuroscience Research Center), College of Medicine, University of Saskatchewan, Saskatoon, SK, S7K 0M7, Canada
2Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hannah E. Salapa
Patricia A. Thibault
1Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, CMSNRC (Cameco MS Neuroscience Research Center), College of Medicine, University of Saskatchewan, Saskatoon, SK, S7K 0M7, Canada
2Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Hutchinson
1Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, CMSNRC (Cameco MS Neuroscience Research Center), College of Medicine, University of Saskatchewan, Saskatoon, SK, S7K 0M7, Canada
2Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Austin Hammond
4Next-Generation Sequencing Facility, University of Saskatchewan, Saskatoon, SK, S7N 5E5, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C. Levin
1Office of Saskatchewan Multiple Sclerosis Clinical Research Chair, CMSNRC (Cameco MS Neuroscience Research Center), College of Medicine, University of Saskatchewan, Saskatoon, SK, S7K 0M7, Canada
2Department of Medicine, Neurology Division, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
5Department of Anatomy, Physiology and Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, SK, S7N 5A2, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Extended Data
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Efficient knock-down of hnRNP A1 in differentiated Neuro-2a cells. A, Undifferentiated Neuro-2a cells were treated with four different siA1 duplex oligonucleotides for 72 h, which showed varying degrees of hnRNP A1 knock-down. B, Quantification of A demonstrating siA1#4 was the most potent siA1 duplex oligonucleotide to significantly decrease hnRNP A1 expression compared with siNEG. Unpaired t test (ns = non-significant, *p < 0.05, **p < 0.01); n = 3 biological replicates. Data are plotted as mean ± SEM. C, Neuro-2a transfection, differentiation and data collection protocol. D, Protein from differentiated Neuro-2a cells treated with either siNEG or siA1 for 72 h were assayed by Western blotting for hnRNP A1 and β-actin. E, Band densitometry of Western blottings as in D demonstrates a significant decrease in hnRNP A1 protein expression after 72 h of treatment with siA1 as compared with siNEG. Unpaired t test (***p < 0.001); n = 3 biological replicates. Data are plotted as mean ± SEM. F, Confirmation of decreased hnRNP A1 expression (green) following treatment with siA1 using immunocytochemistry. Scale bar: 20 μm. G, Corrected total hnRNP A1 nuclear fluorescence was measured using ImageJ. Cells in the siA1 condition demonstrated significant reduction in hnRNP A1 expression as compared with siNEG-treated cells. Unpaired t test (****p < 0.0001); n = 3 biological replicates. Individual cell values (n = 30 cells per replicate) are plotted as mean ± SEM.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    RNA-seq analysis of hnRNP A1 knock-down in differentiated Neuro-2a cells. A, PCA analysis of log transformed normalized RNA-seq data showing that siA1 and siNEG formed distinct clusters with strong intercluster separation. B, Heatmap of DE transcripts plotted as normalized count values for siNEG-treated (n = 3) and siA1-treated (n = 3) cells. C, Volcano plot of siA1-treated samples (siA1 vs siNEG) illustrating significantly upregulated (green dots) and downregulated (red dots) transcripts. Non-DE transcripts are represented as black dots; p threshold of 0.05 is displayed in gray. See Extended Data Figure 2-1 for list of significant DE genes. D–G, GO enrichment analysis of DE genes identified GO terms related to RNA metabolism (D), neuronal functions (E), neuronal morphology (F), cell death (G), and RNP complex (H). Values at the end of each bar represent number of DE genes in each GO process. Data are presented as -log10false discovery rate (FDR) values, which represent p-values adjusted for multiple tests by Benjamini–Hochberg procedure. See Extended Data Figure 2-2 for list of significantly enriched GO terms from biological processes.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    HnRNP A1 binding to DE genes. A, Pie chart representing the subset of DE genes with human orthologs (n = 1341) that had previously been shown to be known hnRNP A1 binding targets (89.86%) and those that had not (10.14%). B, Pie chart representing subset of upregulated DE genes with human orthologs (n = 729) that had previously been shown to be known hnRNP A1 binding targets (88.89%) and those that had not (11.11%). C, Pie chart representing subset of downregulated DE genes with human orthologs (n = 612) that had previously been shown to be known hnRNP A1 binding targets (91.01%) and those that had not (8.89%).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Effect of hnRNP A1 knock-down on neuronal health. A, Immunofluorescent images of Neuro-2a cells stained for DAPI (blue), hnRNP A1 (green), and β-III-tubulin (red) to identify neurites. Cells in the siNEG condition have more neurites that appear longer as compared with the siA1 condition. Scale bar: 20 μm. B, Neurites were traced in the β-III-tubulin channel in ImageJ using the NeuronJ plugin as described in Materials and Methods. Quantification revealed that siA1-treated Neuro-2a cells have significantly fewer neurite branches as compared with the siNEG condition. Unpaired t test (***p < 0.001); n = 3 biological replicates. Individual cell values (n = 30 cells per replicate for siNEG; n = 20 cells with >50% knock-down for siA1) are plotted as the mean ± SEM. C, Corrected total hnRNP A1 nuclear fluorescence of Neuro-2a cells treated with siA1 correlates with neurite branch number. PC test (r = 0.167, r2 = 0.02,799, p = 0.0498); n = 3 biological replicates. Individual cell values (n = 30 cells per replicate) are plotted. D, Neuro-2a cells treated with siA1 have significantly shorter neurites as compared with the siNEG condition. Unpaired t test (***p < 0.001); n = 3 biological replicates. Individual cell values (n = 30 cells per replicate for siNEG; n = 20 cells with >50% knock-down for siA1) are plotted as mean ± SEM. E, Corrected total hnRNP A1 nuclear fluorescence of Neuro-2a cells treated with siA1 correlated with neurite sum length. PC test (r = 0.2959, r2 = 0.08,758, p = 0.0015); n = 3 biological replicates. Individual cell values (n = 30 cells per replicate) are plotted. F, HnRNP A1 knock-down significantly increased cellular cytotoxicity as compared with siNEG-treated cells as measured by the CYQUANT LDH cytotoxicity assay. Unpaired t test (*p < 0.05); n = 3 biological replicates. Data are plotted as mean ± SEM.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    HnRNP A1 knock-down affects SG formation. A, Immunofluorescent images of differentiated Neuro-2a cells treated with siNEG or siA1 for 72 h followed by 30-min treatment with sodium arsenite. Cells are stained for β-III-tubulin (blue), hnRNP A1 (red), and G3BP (green) to identify SGs. Cells in the siNEG condition have significantly more punctate-like G3BP+ granules as compared with the siA1 condition. Scale bar: 20 μm. B, Quantification revealed that sodium arsenite-treated Neuro-2a cells in the siA1 condition form significantly fewer SGs as compared with the siNEG condition. Unpaired t test (****p < 0.0001); n = 3 biological replicates. Individual cell values (n = 90 cells per replicate for siNEG; n = 141 cells with >50% knock-down for siA1) are plotted as mean ± SEM. C, HnRNP A1 cell fluorescence of Neuro-2a cells treated with siA1 followed by sodium arsenite treatment correlates with number of SGs. PC test (r = 0.2825, r2 = 0.07,982, p < 0.0001); n = 3 biological replicates. Individual cell values (n = 90 cells per replicate) are plotted. D, Quantification revealed that sodium arsenite-treated Neuro-2a cells in the siA1 condition have significantly smaller SGs as compared with the siNEG condition. Unpaired t test (****p < 0.0001); n = 3 biological replicates. Individual cell values (n = 90 cells per replicate for siNEG; n = 141 cells with >50% knock-down for siA1) are plotted as mean ± SEM.

Tables

  • Figures
  • Extended Data
    • View popup
    Table 1

    Statistical table

    FigureData structureType of testSample sizeStatistical data
    Figure 1BOne tailedUnpaired t testsiNEG: 3 experimental replicates
    siA1#1: 3 experimental replicates
    siA1#2: 3 experimental replicates
    siA1#3: 3 experimental replicates
    siA1#4: 3 experimental replicates
    siNEG vs siA1#1 p = 0.1471, t = 1.206, df = 4; siNEG vs siA1#2 p = 0.0277, t = 2.678, df = 4; siNEG vs siA1#3 p = 0.0041, t = 4.871, df = 4; siNEG vs siA1#4 p = 0.0011, t = 6.929, df = 4.
    Figure 1EOne tailedUnpaired t testsiNEG: 3 experimental replicates
    siA1: 3 experimental replicates
    p = 0.0005, t = 8.435, df = 4, 95% CI = −1.057 to −0.5336, r2 = 0.9468, difference between means ± SEM = −0.7954 ± 0.09429
    Figure 1GOne tailedUnpaired t testsiNEG: 3 experimental replicates with over 30 cells analyzed per replicate
    siA1: 3 experimental replicates with over 30 cells analyzed per replicate
    p < 0.0001, t = 10.50, df = 193, 95% CI = −27493 to −18797, r2 = 0.3635, difference between means ± SEM = −23145 ± 2205
    Figure 4BOne tailedUnpaired t testsiNEG: 3 experimental replicates with over 90 cells analyzed in total
    Severe siA1: 3 experimental replicates with 20 cells analyzed in total
    p = 0.0002, t = 3.644, df = 116, 95% CI = −2.890 to −0.8547, r2 = 0.1027, difference between the means ± SEM = −1.872 ± 0.5139
    Figure 4DOne tailedUnpaired t testsiNEG: 3 experimental replicates with over 90 cells analyzed in total
    Severe siA1: 3 experimental replicates with 20 cells analyzed in total
    p = 0.0002, t = 3.671, df = 116, 95% CI = −62.74 to −18.76, r2 = 0.1041, difference between the means ± SEM = −40.75 ± 11.10
    Figure 4FOne tailedUnpaired t testsiNEG: 3 experimental replicates
    siA1: 3 experimental replicates
    p = 0.0221, t = 2.900, df = 4,
    95% CI = 0.1822–8.404, r2 = 0.6776
    Figure 5BOne tailedUnpaired t testsiNEG: 3 experimental replicates with over 290 cells analyzed in total
    Severe siA1: 3 experimental replicates with 141 cells analyzed in total
    p < 0.0001, t = 7.480, df = 437, 95% CI = −2.641 to −1.542, r2 = 0.1135, difference between the means ± SEM = −2.091 ± 0.2796
    Figure 5COne tailedPC testsiA1: analyzed 300 cells for their hnRNP A1 fluorescence and SG number; each dot represents a single cellp < 0.0001, r = 0.2825, r2 = 0.07982, 95% CI = 0.1749–0.3835
    Figure 5DOne tailedUnpaired t testsiNEG: 3 experimental replicates with over 290 cells analyzed in total
    siA1: 3 experimental replicates with 141 cells analyzed in total
    p < 0.0001, t = 6.494, df = 443, 95% CI = −0.5998 to −0.3211, r2 = 0.08691, difference between the means ± SEM = −0.4605 ± 0.07091

Extended Data

  • Figures
  • Tables
  • Extended Data Figure 2-1

    List of DE genes with Ensembl transcript IDs, gene symbols, fold changes for each transcript, log2(fold change), p values, adjusted p value (padj), -log(padj), change direction, and significance. Download Figure 2-1, XLS file.

  • Extended Data Figure 2-2

    Significantly enriched GO terms from biological processes grouped into the following categories: RNA metabolism, neuronal function, neurite outgrowth, cell death, and RNP complex. Categories include number of genes (# genes), category, description, false discovery rate (FDR) values, -log(FDR value), genes, p values, and term name. Download Figure 2-2, XLS file.

Back to top

In this issue

eneuro: 8 (6)
eNeuro
Vol. 8, Issue 6
November/December 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells
Amber Anees, Hannah E. Salapa, Patricia A. Thibault, Catherine Hutchinson, S. Austin Hammond, Michael C. Levin
eNeuro 25 October 2021, 8 (6) ENEURO.0350-21.2021; DOI: 10.1523/ENEURO.0350-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells
Amber Anees, Hannah E. Salapa, Patricia A. Thibault, Catherine Hutchinson, S. Austin Hammond, Michael C. Levin
eNeuro 25 October 2021, 8 (6) ENEURO.0350-21.2021; DOI: 10.1523/ENEURO.0350-21.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • heterogeneous nuclear ribonucleoprotein A1
  • Neuro-2a cell line
  • neurodegenerative disease
  • Neuronal cell damage
  • RNA binding protein
  • small interfering RNA

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Astrocyte-derived PTPRZ1 regulates excitatory synapse density in the mouse cortex
  • Neural and behavioral correlates of evidence accumulation in human click-based echolocation
  • Motor protein disruption critically alters organelle trafficking and excitation contraction coupling
Show more Research Article: New Research

Disorders of the Nervous System

  • A Multi-Network Approach Identifies Proteins Related to Dendritic Spines in Alzheimer's Disease
  • Epigenetic and transcriptomic impacts of ethanol vary by brain region and extent of exposure
  • Parvalbumin Neuron–Targeted Loss of Alzheimer’s Disease Risk Gene BIN1 Is Insufficient to Drive Cognitive or Network Excitability Changes
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2026 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.